Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 27, 2004. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares and American Depositary Receipts (ADRs) resulting from employee benefit plan transactions.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on equity movements within employee trusts and plans rather than operational financial performance.
Material Changes
The filing details three specific transactions affecting directors' interests during late February 2004:
- February 23: The GlaxoSmithKline Employee Trust transferred 7,658 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. Directors Dr. J-P Garnier, Dr. T Yamada, and Mr. J D Coombe hold indirect interests in these shares.
- February 23: The SmithKline Beecham Employee Benefit Trust transferred 7,702 Ordinary Shares to participants in the SmithKline Beecham Bonus Investment Plan. Director John Coombe holds an indirect interest in these shares.
- February 26: The GlaxoSmithKline US Retirement Savings Plan reduced its holdings of Ordinary Share ADRs from 18,670,390 to 18,625,106 (a decrease of 45,284 ADRs) at an average price of $42.72. Directors Dr. J P Garnier and Dr. T Yamada hold indirect interests in this fund.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a routine disclosure of director shareholding changes.
Investor Verification Checklist
- Verify the total number of shares held by the GSK Trust and the SmithKline Beecham Employee Benefit Trust to assess the scale of director exposure.
- Confirm the current ADR holdings of the GlaxoSmithKline US Retirement Savings Plan to track ongoing changes in director interests.
- Review the specific terms of the SmithKline Beecham Employee Share Option Plan 1991 and Bonus Investment Plan to understand vesting schedules and potential future share releases.
- Check subsequent filings for any further movements in the US Retirement Savings Plan following the February 26 reduction.